Whether it is necessary to re-test myeloid genes for acute myeloid leukemia at age 70 is not related to age, and genetic testing is recommended for all patients diagnosed with acute myeloid leukemia. Acute myeloid leukemia is particularly important to receive genetic testing, with the development of medicine, more and more leukemia gene sequence mutations are detected, after research and analysis, can be carried out to analyze the prognosis of the disease, and certain gene sequence mutations, has been studied its targeted treatment options. Drugs include Venegra, Sorafenib, etc. Therefore, all patients with acute myeloid leukemia are recommended to further genetic testing, which is helpful for the diagnosis, treatment and prognosis of the disease. Specific medications should be administered under the guidance of a physician.